Robert T. Yanagisawa

ASSOCIATE PROFESSOR Medicine, Endocrinology, Diabetes and Bone Disease

Print Profile

Email

Specialty

Endocrinology, Diabetes and Metabolism

Certifications

Diabetes & Metabolism

Clinical Focus

Education

MD, Brown University
Residency, Internal Medicine
Miriam Hospital
Fellowship, Endocrinology
University of Mass. Medical Center

Biography

Robert Yanagisawa, MD, is an Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai, and is the Program Director of the Clinical Fellowship in Endocrinology, Diabetes and Metabolism. The program has built a reputation for training the most outstanding academic endocrinologists. Dr. Yanagisawa has also made significant contributions in advancing global medical partnerships with the Japanese Medical Society of America. With the Mount Sinai Global Health Training Program, he has established a new training site in Japan for Disaster Medical Sciences in Fukushima, following a nuclear power plant fallout involving relocation of over 160,000 people in 2011. He has introduced a new multidisciplinary approach with collaborations between disaster psychiatry and radiation biology for a long-term post disaster recovery. The innovative efforts have been commended by former First Lady of Japan, the Ministry of Foreign Affairs, and the Reconstruction Agency of Japan.

View the PDF

Publications

Carluccio A, Sundaram N, Yanagisawa R, Tomer Y. Apathetic thyrotoxicosis secondary to atypical subacute thyroiditis . Endocrine Pract 2012 Sep; 1;18.

Rao R, Yanagisawa R R, Kini S. Insulin Resistance and Bariatric Surgery. Obes Rev 2012 Apr; 13(4):: 316-28.

Owen R, Chou K, Silver C, Beilin Y Y, Tang J, Yanagisawa R, Rinaldo A, Shaha A, Ferlito A. Thyroid and Parathyroid Surgery in Pregnancy . Eur Arch Otorhinolaryngol 2010; 267: 1825-1835.

Strohmayer E, Via M, Yanagisawa R. Metabolic Management following Bariatric Surgery. MSJM 2010; 77: 431–445.

Siram A, Yanagisawa R, Skamagas M. Weight Management in Type 2 Diabetes Mellitus . MSJM 2010; 77: 533–548.

Yanagisawa R, LeRoith D. Editorial, Theme Issue: The Obesity Pandemic: Meeting the Clinical Challenges . MSJM 2010; 77(5).

Potenza M, Via M, Yanagisawa R. Excess Thyroid Hormone and Carbohydrate Metabolism. Endocrine Practice 2009 Apr; 15(3): 254-62.

Kini S, Herron D, Yanagisawa R. Surgical Therapy for Morbid Obesity – A cure for all metabolic syndrome?. Med Clin North Am 2007; 91(6): : 1255-1271.

Metabolic Syndrome and Type 2 Diabetes: Can we stop the weight gain with diabetes?. Med Clin North Am 2007; 91(6): 1107-1123.

Yanagisawa R, LeRoith D. Editorial, Metabolic Syndrome Issue. Med Clin North Am 2007; 91(6).

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Yanagisawa did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central